^
    2years
    NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor (clinicaltrials.gov)
    P1, N=12, Not yet recruiting, Peking University
    New P1 trial • Metastases
    |
    KD-496
    3years
    NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors (clinicaltrials.gov)
    P1, N=18, Recruiting, jianming xu
    New P1 trial • Metastases
    |
    CLDN18 (Claudin 18)
    |
    KD-496